Currently, the mainstay of disease management for hemophilia B, a hemorrhagic disease caused by a congenital deficiency or molecular abnormalities of blood coagulation factor IX (FIX), is prophylaxis using FIX concentrate. The gene discussed is F9; the disease is hyperinsulinemic hypoglycemia, familial, 4.